Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by Dehydroxymethylepoxyquinomicin
Open Access
- 1 July 2002
- journal article
- Published by Elsevier
- Vol. 277 (27) , 24625-24630
- https://doi.org/10.1074/jbc.m112063200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin CBioorganic & Medicinal Chemistry Letters, 2000
- Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofenOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Transport Between the Cell Nucleus and the CytoplasmAnnual Review of Cell and Developmental Biology, 1999
- Induction of Apoptosis of Cytokine-Producing Bladder Cancer Cells by Adenovirus-Mediated I kappa B alpha OverexpressionHuman Gene Therapy, 1999
- An Allosteric Drug,o,o′-Bismyristoyl Thiamine Disulfide, Suppresses HIV-1 Replication through Prevention of Nuclear Translocation of both HIV-1 Tat and NF-κBBiochemical and Biophysical Research Communications, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Inhibition of NF-κB Activation by PanepoxydoneBiochemical and Biophysical Research Communications, 1996
- Two TNF receptorsImmunology Today, 1992
- Tumor Necrosis Factor (TNF)Science, 1985